BofA/Merrill Lynch Downgrades Regeneron Pharma (REGN) to Underperform
Go back to BofA/Merrill Lynch Downgrades Regeneron Pharma (REGN) to Underperform| Regeneron (NASDAQ: REGN) | Delayed: 803.23 -2.74 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $805.97 | 52 Week High | $592.36 | |||
| Open | $802.35 | 52 Week Low | $325.35 | |||
| Day High | $806.54 | P/E | 210.82 | |||
| Day Low | $792.57 | EPS | $3.81 | |||
| Volume | 227,995 | |||||

